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Abstract 
Amino acids carrying aromatic carbo- and heterocycles in the side chain, such as naphthyl-, 
biphenyl- and pyridylalanines, have been prepared by alkylation of a glycine enolate with a 
haloalkyl carbocycle or heterocycle, with enantiomeric excess up to 87% using the ephedrine 
amide protocol. 
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Introduction 
 
We have a programme to prepare unusual α-amino acids including those carrying carbocyclic 
and heterocyclic moieties not covered by the proteinogenic set: phenylalanine, tyrosine, histidine 
and tryptophan.1,2 With this in mind we have investigated the disconnection of Scheme 1, 
involving a glycine enolate equivalent and a side-chain electrophile. The glycine enolate had to 
be optically active to induce asymmetry during the alkylation process, and we elected to explore 
the enolate derived from the ephedrine-based glycinamide 1.3 We detail herein our findings on 
the synthetic methodology, and the synthesis of naphthylalanine, biphenylalanine, the 
regioisomers of pyridylalanine, and an isoxazole derivative. Although some of these compounds 
have been reported,4 we are not aware of the application of the alkylation of glycine enolates to 
their construction.5 
 
                                                 
‡ Ray Jones was Secretary and Treasurer of the RSC Heterocyclic Group  during the period 1992-1996 and 
Chairman during the period 2001-2003 
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Scheme 1. Disconnection to form amino acids. 
 
 
Results and Discussion 
 
From the possible glycine enolate sources, we selected the ephedrine-based glycinamide 1 
developed by Myers,3 based on the low cost and availability (of both enantiomers) of the 
precursors, the tendency of pseudoephedrine amides to be crystalline, and the reported high 
diastereoselectivity of the alkylation reaction and facile removal of the chiral auxiliary. 
Furthermore, the manipulations are performed without the need for protection on the glycine 
amino group, so that in principle unnatural amino acids are prepared in three steps in good yields 
and enantiomeric excess. 
 The first task was to prepare the glycine pseudoephedrine amide 1. This was performed 
using (1R,2R)-pseudoephedrine and glycine methyl ester under the basic conditions of Myers.6 
We found that treatment of glycine methyl ester hydrochloride in dry diethyl ether with dry 
ammonia for 3-4 h, followed by filtration of the ammonium chloride and careful concentration of 
the ethereal solution afforded a sufficiently pure solution of the glycine methyl ester and avoided 
the need for distillation,6 whereas the use of triethylamine (1 equiv.) in dry ether to neutralize the 
ester salt resulted in the formation of unwanted side-products in the later alkylation. The 
coupling protocol involved deprotonation of the hydroxyl group with n-butyllithium (0.8 equiv.) 
in THF in the presence of anhydrous lithium chloride at 0 ºC and addition of the ethereal glycine 
methyl ester solution (1.2 equiv.). High yields (up to 80%) were only obtained when rigorously 
dried LiCl was used and the glycine ester solution was added slowly over 1.5 h. The glycinamide 
1 was obtained as a hydrate without chromatography, and it was essential to dehydrate this using 
anhydrous potassium carbonate and subsequent recrystallisation from toluene. This material 
could be satisfactorily stored in vacuo over P2O5. 
 There are three sites for deprotonation of 1, the secondary hydroxyl group, the amino 
group and the desired α-carbon. It has been shown that 2 equiv. of base gives the N,O-dianion A 
as kinetic product at –78 ºC, but that after warming to 0 ºC the thermodynamic C,O-dianion B is 
formed, a glycine enolate that can undergo C-alkylation.3,7 Since decomposition has been found 
to result from use of excess base (>2 equiv.), the reported protocol for enolate formation is to add 
LDA (1.95 equiv.) in THF dropwise to a slurry of the amide 1 (1 equiv.) and anhydrous LiCl (6 
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equiv.) in dry THF; we have performed this at 0 ºC, rather than at –78 ºC, then warming to 0 ºC. 
In our hands, when >2 equiv. of LDA was present, free pseudoephedrine was liberated and the 
reaction mixture developed an orange coloration in contrast to the normal yellow colour. We 
used this as a titration for the amount of LDA, stopping base addition when the solution was still 
just yellow, even if this meant using less than the calculated 1.95 equiv. of base. We adopted this 
protocol, using a slurry of anhydrous pseudoephedrine glycinamide and flame-dried LiCl in THF 
at 0 ºC under argon, adding freshly prepared LDA solution over 30 min until just before the 
colour change, and then after stirring for 30 min at 0 ºC, adding a solution of a haloalkane (1.1-
1.2 equiv.) in THF. After a further period of 2 h at 0 ºC, the mixture was worked up to provide 
the C-alkylation product. The use of commercial LDA solutions was found to give less 
satisfactory results. It also proved necessary to dry the LiCl under vacuum for 12 h, then to 
flame-dry it prior to use and cool it under argon.8 
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Scheme 2 
 
 Using this protocol, we first validated the method using benzyl bromide as electrophile. 
The alkylation product 2a was obtained in 62% yield. As expected, it displayed rotational 
isomerism in the 1H and 13C NMR spectra, for example two NCH3 signals, δH 2.60 & 2.90, δC 
27.1 & 30.4. VT-NMR studies up to 100 ºC did not show peak coalescence. Attempts to 
determine diastereoisomer ratios by HPLC or chiral column GC were unsuccessful. We therefore 
proceeded directly to hydrolytic removal of the chiral auxiliary. 
 The hydrolysis of glycinamide alkylation products was originally reported by heating 
under reflux in a slightly alkaline solution.3 However, we noted that the products of alkylation 
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displayed some water solubility to produce alkaline solutions, presumably due to the presence of 
the free amino group. We therefore found that simply heating a solution of the alkylation product 
in water-dioxane for 12 h led to quantitative hydrolysis to afford the free amino acid plus 
pseudoephedrine.8 The latter was removed by extraction with DCM. Evaporation of the aqueous 
layers and subsequent trituration of the crude amino acid in ethanol served to remove any 
residual traces of pseudoephedrine. An advantage of this simple hydrolysis is that the amino acid 
product does not require a desalting procedure such as ion exchange chromatography.8 
 Using the above procedure, phenylalanine 3a was isolated from 2a in 76% yield, and pure 
pseudoephedrine was recovered in 70% yield. To assess the enantiomeric purity of the acid 
obtained, the NMR method of Mosher was employed.9 Thus, the amino acid was esterified using 
HCl solution in ethanol, and treating the ester with (R)-2-methoxy-2-phenyl-3,3,3-
trifluoropropanoyl chloride [(R)-MTPA-Cl]. 19F NMR spectroscopy of the ‘Mosher amide’ 4a 
produced in this way from the above sample of phenylalanine displayed two singlets at δF –
69.087 (major) and –69.141 (minor), and the ratio indicated an e.e of 87%.11 To check the chiral 
integrity during the sequence, commercial (S)-phenylalanine ethyl ester hydrochloride was 
coupled to (1R,2R)-pseudoephedrine using the same conditions as the coupling with glycine, the 
amide hydrolysed and the amino acid converted in the same way into the Mosher amide. The 19F 
NMR spectrum showed one peak only, corresponding to the major diastereoisomer of 4a. This 
sequence was repeated starting with commercial (R)-phenylalanine and (1S,2S)-
pseudoephedrine, and the Mosher amide displayed just one peak in the 19F NMR spectrum, now 
corresponding to the minor diastereoisomer of 4a. These results confirmed that (i) the e.e of 87% 
was due to the diastereoselectivity in the pseudoephedrine glycinamide alkylation step, and (ii) 
that the alkylation of (R,R)-pseudoephedrine glycinamides produces predominantly the (S)-
amino acids. This latter is in line with the reported predictive mnemonic of 1,4-syn products 
when the (Z)-enolate is drawn in a planar extended conformation (Figure 1).7 
 
Ph
N
H2N
OH
CH3
CH3
O
R
Ph
N
H2N
OLi
CH3
CH3
OLi
B: thermodynamic dianion 2
1,4-syn
RX
 
 
Figure 1. Mnemonic for prediction of stereochemistry of alkylation products 2. 
 
 With the synthetic protocols and analytical methodology in place and validated, we were in 
a position to extend the sequence to other haloalkyl hetero- and carboaromatics that would afford 
non-proteinogenic amino acids. Therefore, we reacted the glycinamide 1 according to the 
procedures detailed above with the following commercially available halides: 1-
chloromethylnaphthalene, 1-(2-bromoethyl)naphthalene, 2-phenylbenzyl chloride, 2-
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chloromethylpyridine, 3-chloromethylpyridine, 4-chloromethylpyridine and 4-chloromethyl-3,5-
dimethylisoxazole. This afforded the alkylation products 2b-h in yields of 33-97% (see Table 1) 
as sticky oils that could not be crystallized; in the pyridyl cases, the chlorides proved unstable 
after liberation from the purchased hydrochloride salts, and the alkylation products 2e-g could 
not be fully purified for spectroscopic analysis. We thus decided to subject these alkylation 
products to hydrolysis directly. 
 
Table 1. Alkylation of 1 to form amides 2, hydrolysis to amino acids 3, and determination of ee 
by conversion into Mosher amides 4 
Entry R Alkylated amide 
2 (% yield) 
Amino acid 
3 (% yield) 
ee of 3 (from 
Mosher amide 4) 
1 CH2Ph 2a (62) 3a (76) 87 
2 CH2(1-naphthyl) 2b (61) 3b (76) 87 
3 CH2CH2(1-naphthyl) 2c (33) 3c (74) 61 
4 CH2(2-PhC6H4) 2d (68) 3d (48) 74 
5 CH2(2-pyridyl) 2e (62*) 3e (59) 10 
6 CH2(3-pyridyl) 2f (55*) 3f (49) 74 
7 CH2(4-pyridyl) 2g (36*) 3g (40) 68 
8 CH2(3,5-dimethylisoxazol-4-yl) 2h (97) 3h (59) 74 
* crude yields (see text) 
 
 The amides 2b-h, in a minimum amount of dioxan to ensure solution, were hydrolysed in 
water at reflux as outlined above to afford, after DCM extraction to remove pseudoephedrine, 
evaporation of the aqueous layer to dryness and trituration of the residue with ethanol, the non-
proteinogenic amino acids 3b-h. The progress of hydrolysis was monitored by HPLC and found 
to be complete after 12 h. In our hands this procedure afforded the amino acids 3b-h in yields of 
40-76% (Table 1) with good purity. This procedure assisted in the purification of the pyridyl 
derivatives 3e-g, although the amino acids were somewhat soluble in ethanol, which may 
account for the reduced isolated yields. 
 In order to determine the enantiomeric purity of the acids 3b-h, they were subjected to the 
sequence developed above for preparation of the Mosher’s amides 4b-h, via synthesis of their 
ethyl ester hydrochlorides (EtOH, HCl, reflux) and reaction with (R)-MTPA-Cl. The 
diastereomer mixtures were examined by 19F NMR spectroscopy; in each case the presence of 
two singlets revealed the presence of two diastereoisomers. The de values, calculated from the 
integrals and which can be equated to ee values for the amino acids 3b-h, were in the range 61-
87% (Table 1), with the exception of the 2-pyridyl case 3e (10%). We assume, based on 
precedent, that the major isomers have the (S)-configuration. The ee values were not as high as 
has been reported,7 and not always reproduced, most likely due to difficulties in determination of 
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the end-point for BuLi addition to 1 to form its enolate, and to variability in the physical state of 
the LiCl, both critical factors in the alkylation protocol, vide supra. 
 Nevertheless, we have successfully prepared several interesting non-proteinogenic amino 
acids carrying aromatic side chains via a flexible glycine enolate approach that could be easily 
extended to a range of carbo- and heteroaromatic moieties. We also report several technical 
issues in the experimental protocols.8 The naphthyl and biphenyl amino acids 3b-d are potential 
nucleic acid intercalators,11 the pyridylalanines 3e-g have been used as histidine replacements 
and have diverse pharmacological effects,12 and the isoxazolyl amino acid 3h is an analogue of 
2-amino3-(3-hydroxy-5-methylisazol-4-yl)propionic acid (AMPA), an excitatory amino acid.13 
 
 
Experimental Section 
 
General Procedures. Melting points were determined using a Kofler hot-stage apparatus and are 
uncorrected. Infrared spectra were recorded using a Perkin-Elmer 1710 FT-IR spectrometer. 19F 
NMR spectra were obtained at 376 MHz on a JEOL JNM-EX400 spectrometer, and 1H and 13C 
NMR spectra recorded at 300 MHz or at 75 MHz, respectively, on a JEOL JNM-LA300 
spectrometer, in deuteriochloroform unless otherwise stated. Low-resolution mass spectra were 
recorded on a VG Micromass VG20-250 spectrometer, or by the EPSRC National Mass 
Spectrometry Service Centre (University of Wales Swansea) who also performed the accurate 
mass measurements. All reagents were purified by distillation or recrystallisation where 
appropriate, or according to standard procedures. Column chromatography was carried out using 
Fluka Silica Gel 60 (220-440 mesh). TLC analysis was performed using Macherey-Nagel 
Polygram SIL G/UV254 plates and visualized by UV light or aqueous KMnO4 spray 
(KMnO4:K2CO3:water 6:1:100 w/v/v). Organic extracts were dried over anhydrous MgSO4. 
General method for alkylation of pseudoephedrine glycinamide (1). A freshly prepared 
solution of LDA (2M, 1.95 equiv.) in hexanes was added over 0.25-0.5 h to a stirred slurry of 
anhydrous pseudoephedrine glycinamide 13 (1.0 equiv.) and flame-dried LiCl (6 equiv.) in THF 
under a positive argon atmosphere at 0 ºC. After stirring at 0 C for 0.5-1 h, the haloalkane (1.1 
equiv.) was added dropwise. After 12 h, hydrochloric acid (1M) was added, followed by ethyl 
acetate. The organic layer was extracted with a second portion of hydrochloric acid (1M). The 
aqueous extracts were combined and the resulting solution was cooled in an ice-bath and 
carefully basified to pH 14 by addition of aqueous sodium hydroxide solution (50%). The basic 
aqueous solution was extracted with DCM. The combined organic extracts were combined and 
dried over potassium carbonate, filtered and concentrated under reduced pressure to provide the 
alkylated products 2. 
(1R,2R,2’S)-2’Amino-3’-phenylpropanoylpseudoephedrine (2a). Prepared as above using 
LDA (2M, 17.56 mL, 0.035 mol), (1R,2R)-pseudoephedrine glycinamide 1 (4.00 g, 18 mmol) 
and lithium chloride (4.58 g, 108 mmol) in THF (100 mL), with benzyl bromide (3.39 g, 20 
mmol) in THF (10 mL). After 2 h, hydrochloric acid (1M, 100 mL) was added followed by ethyl 
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acetate (200 mL). The organic layer was extracted with a second portion of hydrochloric acid 
(1M, 100 mL). The aqueous extracts were combined, cooled, basified and extracted with DCM 
(3 x 80 mL). Removal of the solvent provided a hygroscopic solid residue (3.45 g, 62%), RF = 
0.53 (DCM:MeOH:Et3N 90:5:5 v/v/v); Found: MH+ (ES+) 313.1908. C19H24N2O2 requires: MH 
313.1916. νmax/cm–1 (KBr) 3300, 3250, 1625, 1500, 1450, 1400, 1300, 1100; δH (4:1 rotamer 
ratio, the asterisk denotes the minor isomer) 0.88 and 0.99* (3H, d, J 6.2, CHCH3), 2.60 and 
2.90* (3H, s, NCH3), 2.70-2.82 (2H, 2 x dd, J 13.2 and 7.2, CHCH2), 3.70 (1H, t, J 7.1, CHCH2), 
4.30 and 4.45* (IH, d, J 6.6, CHOH), 4.60 and 4.70* (1H, m, CHCH3), 7.00-7.30 (10H, m, ArH); 
δC 14.4 and 15.5* (CHCH3), 27.1* and 30.4 (NCH3), 41.9* and 30.4 (CH2) 53.2 (CHCH2), 56.5 
and 57.9* (CHCH3), 75.0* and 75.6 (CHOH), 126.5, 126.6, 126.7, 126.8, 127.7, 128.2, 128.3, 
128.4, 128.5, 128.6, 129.2, 129.4 (6 x ArCH and 6 x ArCH*), 137.5 and 138.4*, 141.7* and 
142.0 (2 x ArC), 175.2* and 176.2 (C=O); m/z (CI) 313 (MH+, 100%), 295 (40), 277 (25), 267 
(15), 255 (60), 231 (30). 
(1R,2R,2'S)-2'-Amino-3'-(1-naphthyl)propanoylpseudoephedrine (2b). Prepared by the 
general method, using (1R,2R)-pseudoephedrine glycinamide 1 (2 g, 9 mmol), LDA (8.78 mL, 
18 mmol), lithium chloride (2.29 g, 54 mmol) and 1-chloromethylnaphthalene (1.67 g, 9.5 
mmol). After the usual extraction, the yellow gum was purified by column chromatography 
(DCM:MeOH:Et3N 90:5:5 v/v/v) to yield the title compound as a yellow hygroscopic gum (1.98 
g, 61%). Found: MH+ (ES+) 363.2076. C23H26N2O2 requires: MH 363.2072. νmax/cm–1 (film) 
3400, 3200, 2850, 1650, 1300, 950; δH (4:1 rotamer ratio, the asterisk denotes the minor isomer) 
0.90 and 1.00* (3H, d, J 4.9, CHCH3), 2.60 (3H, s, NCH3), 3.10 and 3.20 (2H, 2 x dd, J 5.4 and 
9.9, CHCH2), 3.80 and 3.90* (1H, t, J 5.4, CHCH2), 4.15* and 4.40 (IH, m, CHCH3), 4.10 and 
4.20* (1H, d, J 6.7, CHOH), 6.90-7.90 (12H, m, ArH); δC 15.2 and 15.6* (CHCH3), 29.8* and 
30.8 (NCH3), 39.4 and 39.5* (CH2), 52.2 and 56.9* (CHCH2), 53.7 and 68.9* (CHCH3), 75.6 
and 75.5* (CHOH), 123.3, 123.4, 125.3, 125.4, 125.6, 126.1, 126.2, 126.3, 126.7, 126.8, 127.4, 
127.5, 127.7, 128.1, 128.3, 128.4, 128.8, 128.9, 131.9 and 132.0 (10 x ArCH and 10 x ArCH*), 
132.2 and 133.6*, 133.8 and 134.2*, 135.1 and 135.3*, 141.9 and 142.0* (4 x ArC), 176.3* and 
176.4 (C=O); m/z (CI) 363 (MH+, 100%), 230 (20) and 166 (100). 
(1R,2R,2'S)-2'-Amino-4'-(1-naphthyl)butanoylpseudoephedrine (2c). Prepared by the general 
method, using (1R,2R)-pseudoephedrine glycinamide 1 (1.51 g, 6.77 mmol), LDA (6.60 mL, 
13.21 mmol), lithium chloride (1.73 g, 40.64 mmol) and 1-(2-bromoethyl)naphthalene (1.75 g, 
7.45 mmol). After the usual extraction, the yellow hygroscopic gum was purified by column 
chromatography (DCM:MeOH:Et3N 90:5:5 v/v/v), to yield the title compound as a yellow gum 
(0.85 g, 33%). νmax/cm–1 (film) 3400, 3050, 3000, 1650, 1450, 1250, 750; δH (4:1 rotamer ratio, 
the asterisk denotes the minor isomer) 0.65* and 0.80 (3H, d, J 4.9, CHCH3), 1.60-1.75 (2H, m, 
CH2), 2.40 (3H, s, NCH3), 2.95-3.05 (211, m, CH2), 3.40 and 3.65* (1H, m, CHCH2), 3.80* and 
4.35 (1H, m, CHCH3), 4.40 (1H, m, CHOH), 7.00-7.35 (9H, m, ArH), 7.60 (1H, d, J 5.4, ArH), 
7.70 (1H, d, J 5.4, ArH), 7.85 and 8.10* (1H, d, J 5.4, ArH); δC 14.0 and 15.5* (CHCH3), 29.0 
(CH2), 31.0* and 46.0 (NCH3), 35.0 and 36.0* (CH2), 51.0 (CHCH2), 63.0 and 75.0* (CHOH), 
57.0* and 75.4 (CHCH3), 123.5, 123.7, 124.0, 125.4, 125.6, 125.7, 126.0, 126.1, 126.2, 126.4, 
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126.7, 127.0, 127.5, 127.6, 127.8, 127.9, 128.1, 128.3, 128.5 and 128.6 (10 x ArCH and 10 x 
ArCH*), 131.6 and 131.8*, 133.7, 137.4 and 138.0*, 141.7* and 142.1 (4 x ArC), 175.9* and 
176.8 (C=O); m/z (CI) 377 (MH, 70%), 355 (60) and 337 (80). 
(1R,2R,2'S)-2'-Amino-3'-(2-phenylphenyl)propanoylpseudoephedrine (2d). Prepared 
following the general method using (1R,2R)-pseudoephedrine glycinamide 1 (2.50 g, 11.3 
mmol), lithium chloride (2.86 g, 67.5 mmol), LDA (10.9 mL, 21.8 mmol) and 2-phenylbenzyl 
chloride (3.06 g, 12.4 mmol) to yield the title compound as a white hygroscopic powder (2.97 g, 
68%). Found: MH+ (ES+) 389.2234. C25H28N2O2 requires: MH 389.2229. νmax/cm–1 (film) 3100, 
3000, 1256, 750, 700; δH (4:1 rotamer ratio, the asterisk denotes the minor isomer) 0.60* and 
0.90 (3H, d, J 4.9, CHCH3), 2.00 (3H, s, NCH3), 2.40 and 2.80 (2H, 2 x dd, J 8.7 and 11.7, CH2), 
3.30 and 3.40* (1H, m, CHCH2), 3.20 (1H, m, CHCH3), 4.40 (1 H, d, J 6.3, CHOH), 7.10-7.40 
(14H, m, ArH); δC 14. 1 and 14.2 (CHCH3), 31.0 (NCH3), 39.2* and 39.5 (CHCH2), 50.6* and 
51.8 (CHCH2), 74.8* and 75.0 (CHOH), 75.4 (CHCH3), 126.0, 126.1, 126.3, 126.8, 126.9, 127.2, 
127.4, 127.5, 127.6, 128.2, 128.4, 128.6, 128.8, 129.1, 129.3, 130.2, 130.4, 130.5, 130.6, 131.0 
(10 x ArCH and 10 x ArCH*), 132.0 and 132.3*, 133.0 and 133.2*, 141.0 and 141.2*, 141.9* 
and 142.2 (4 x ArC), 175.0* and 176.1 (C=O); m/z (CI) 389 (MH+, 40%), 166 (100) and 58 (15). 
(1R,2R,2'S)-2'-Amino-3'-(2-pyridyl)propanoylpseudoephedrine (2e). 2-Chloromethylpyridine 
hydrochloride (5 g, 30.5 mmol) and triethylamine (3.1 g, 30,5 mmol) were stirred for 3 h at room 
temperature in dry THF (100 mL) under an atmosphere of nitrogen. The triethylamine 
hydrochloride salt was filtered off and the solution reduced to 20 mL under reduced pressure and 
used immediately in the alkylation. The alkylated compound was prepared following the general 
method, using (1R,2R)-pseudoephedrine glycinamide 1 (5.64 g, 25.4 mmol), lithium chloride 
(6.46 g, 152.4 mmol), LDA (24.4 mL, 48.8 mmol) and 2-chloromethylpyridine (3.89 g, 30 
mmol). The crude brown gum (6.2 g) that was obtained was subjected several times to column 
chromatography (DCM:MeOH:Et3N 90:5:5 v/v/v) to yield the title compound (4.95 g, 62%) 
which was used directly in the next step. 
(1R,2R,2'S)-2'-Amino-3'-(3-pyridyl)propanoylpseudoephedrine (2f). 3-Chloromethylpyridine 
hydrochloride (3 g, 18.3 mmol) and triethylamine (1.85 g, 18.3 mmol) were stirred for 3 h at 
room temperature in dry THF (100 mL) under an atmosphere of nitrogen. The triethylamine 
hydrochloride salt was filtered off and the solution reduced to 20 mL under reduced pressure and 
used immediately in the alkylation. The alkylated compound was prepared following the general 
method, using (1R,2R)-pseudoephedrine glycinamide 1 (3.4 g, 15.3 mmol), lithium chloride 
(3.89 g, 91.8 mmol), LDA (14.9 mL, 29.8 mmol) and 3-chloromethylpyridine (2.33 g, 18.3 
mmol). The brown gum that was obtained was subjected several times to column 
chromatography (DCM:MeOH:Et3N 90:5:5 v/v/v) to yield the title compound (2.65 g, 55%) 
which was used directly in the next step. 
(1R,2R,2'S)-2'-Amino-3'-(4-pyridyl)propanoylpseudoephedrine (2g). 4-Chloromethyl-
pyridine hydrochloride (3 g, 18.3 mmol) and triethylamine (1.85 g, 18.3 mmol) were stirred for 3 
h at room temperature in dry THF (100 mL) under an atmosphere of nitrogen. The triethylamine 
hydrochloride salt was filtered off and the solution reduced to 20 mL under reduced pressure and 
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used immediately for the alkylation. The alkylated compound was prepared following the 
general method, using (1R,2R)-pseudoephedrine glycinamide 1 (2.96 g, 13.3 mmol), lithium 
chloride (3.4 g, 80.2 mmol), LDA (13 mL, 26.0 mmol) and 4-chloromethylpyri dine (2.04 g, 16.0 
mmol). The black gum that was obtained was subjected several times to column chromatography 
(DCM:MeOH:Et3N 90:5:5 v/v/v) to yield the title compound as a brown hydroscopic solid (1.5 
g, 36%) which was used directly in the next step. 
(1R,2R,2'S)-2'-Amino-3'-(3,5-dimethylisoxazol-4-yl)propanoylpseudoephedrine (2h). 
Prepared following the general method using (1R,2R)-pseudoephedrine glycinamide 1 (5.88 g, 
26.5 mmol), lithium chloride (6.73 g, 159 mmol), LDA (25.8 mL, 51.6 mmol) and 4-
chloromethyl-3,5-dimethylisoxazole (4.24 g, 29.1 mmol) to yield the title compound as a white 
hygroscopic powder (8.46 g, 97%). Found: MH+ (ES+) 332.1976. C18H25N3O3 requires: MH 
332.1974. νmax/cm–1 (film) 3390, 2950, 2900, 1650, 1450, 1400, 1250, 1200, 1050, 750, 700; δH 
(4:1 rotamer ratio, the asterisk denotes the minor isomer) 0.66* and 0.77 (3H, d, J 4.8, CHCH3), 
2.05* and 2.10 (3H, s, isoxazole CH3), 2.15* and 2.25 (3H, s, isoxazole CH3), 2.35 and 2.45 (2H, 
2 x dd appears as multiplets, CHCH2), 2.65 (3H, s, NCH3), 3.60 and 3.80* (1H, m, CHCH2), 
4.30* and 4.40 (1H, d, J 6.6, CHOH), 4.64 (1H, m, CHCH3), 7.19-7.27 (5H, m, ArH); δC 10.0 
and 10.5* (isoxazole CH3), 11.0 and 11.5* (isoxazole CH3), 14.0 and 14.5* (CHCH3), 28.0 and 
28.5* (CHCH2), 31.0 (NCH3), 51.0 and 51.5* (CHCH2), 55.8 (CHCH3), 75.0 and 75.5* 
(CHOH), 109.5 and 110.0* (ArC), 126.3, 126.5, 126.6, 126.7, 126.9, 127.6, (3 x ArCH and 3 x 
ArCH*), 141.0 and 141.5*, 159.0 and 159.5*, 166.0 and 166.5* (3 x ArC), 175.0* and 176.0 
(C=O); m/z (CI) 332 (MH+, 100%), 166 (65),112 (18), and 58 (20). 
General method for the hydrolysis of alkylated pseudoephedrine glycinamides 
The alkylated pseudoephedrine glycinamide 2 was dissolved in the minimum volume of dioxane 
and water was added. The solution was then heated at reflux for 12 h, cooled to 20 ºC and diluted 
with water. This solution was extracted with DCM (2 x 25 mL). The combined organic extracts 
were extracted with water. The aqueous layers were combined and concentrated under reduced 
pressure to afford a white solid. The solid was triturated in ethanol to remove residual 
pseudoephedrine, filtered and dried in vacuo to give the free amino acid. The combined organic 
extracts were dried over potassium carbonate, filtered, and concentrated to afford 
pseudoephedrine. 
Phenylalanine (3a). Prepared following the general method, using amide 2a (2g, 6.4 mmol) in 
dioxane (5 mL) and water (25 mL). Work-up afforded pseudoephedrine (1.0g, 70%) and the title 
compound (0.81 g, 76%); data in accord with genuine sample, e.g. δH (D2O) 2.95 and 3.15 (2H, 2 
x dd, J 8.0, 14.5 and 5.2, CH2), 3.83 (1H, dd, J 8.0 and 5.2, CHCH2), 7.16-7.26 (5H, m, ArH); δC 
(D2O) 37.2 (CH2), 56.8 (CH), 128.5, 129.9 and 130.2 (3 x ArCH), 135.9 (ArC), 174.74 (C=O). 
2-Amino-3-(1-naphthyl)propanoic acid (3b). Prepared following the general method, using 
amide 2b (0.36g, 4.1 mmol) in dioxane (2 mL) and water (10 mL). Work-up afforded 
pseudoephedrine (0.11g, 50%) and the title compound (0.16 g, 76%). M.p. 185-186 ºC (lit.14 179 
ºC); Found: MH+ (ES+) 216.1022. C13H13NO2 requires: MH 216.1024; νmax/cm–1 (KBr) 3100, 
2600, 2300, 1675, 1600, 1500, 1400, 1350, 1150, 800, 750; δH (D2O) 3.17 and 3.78 (2H, 2 x dd, 
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J 5.3, 8.5 and 14.5, CH2), 3.95 (1H, dd, J 5.3 and 8.5, CH), 7.33-7.89 (7H, m, ArH); m/z (CI) 216 
(MH+, 20%), 170 (100) and 145 (40). 
2-Amino-4-(1-naphthyl)butanoic acid (3c). Prepared following the general method, using 
amide 2c (0.75 g, 4.2 mmol) in dioxane (5 mL) and water (20 mL). Work-up afforded 
pseudoephedrine (0.19g, 58%) and the title compound (0.34 g, 74%) as a hygroscopic solid. 
Found: MH+ (ES+) 230.1181. C14H15NO2 requires: MH 230.1181; νmax/cm–1 (KBr) 3150, 2600, 
2350, 1670, 1620, 1500, 1410, 1350, 1150, 850; δH (D2O) 2.15 (2H, m, CHCH2), 3.20 (2H, m, 
CH2), 3.80 (IH, t, J 7.2, CHCH2), 7.30-7.80 (7H, m, ArH); m/z (El) 229 (M+, 12%), 167 (50), 
141 (100) and 115 (50). 
2-Amino-3-(2-phenylphenyl)propanoic acid (3d). Prepared following the general method, 
using amide 2d (1.54 g, 3.95 mmol) in dioxane (5mL) and water (20 mL). Work-up afforded 
pseudoephedrine (0.69 g, 78%) and the title compound (0.46g, 48%). M.p. 190-191 ºC; Found: 
MH+ (ES+) 242.1189. C15HI5NO2 requires: MH 242.1181; νmax/cm–1 (KBr) 3400, 3000, 1600, 
1500, 1450, 1400, 1350, 1150, 800, 750, 700; δH (D2O) 2.9 (1H, dd, J 7.2 and 10.9, CHH), 3.62 
(1H, dd, J 3.9 and 10.9, CHH), 3.69 (1H, dd, J 3.9 and 7.2, CHCH2), 7.30-7.60 (9H, m, ArH); δC 
(D2O) 36.0 (CH2), 56.4 (CHCH2), 128.0, 128.3, 129.6, 129.7, 130.3, 130.8 and 131.7 (7 x 
ArCH), 134.7, 142.5 and 144.1 (3 x ArC), 173.8 (C=O); m/z (CI) 242 (MH+, 28%) and 196 
(100). 
2-Amino-3-(2-pyridyl)propanoic acid (3e). Prepared following the general method, using 
amide 2e (1.15 g, 3.67 mmol) in dioxane (5 mL) and water (20 mL). Work-up afforded the title 
compound (0.36 g, 59%). M.p. 206-209 ºC (lit.15 210-211 ºC); Found: MH+ (ES+) 167.0820. 
C8H10N2O2 requires: MH 167.0820; νmax/cm–1 (KBr) 3400, 2950, 2850, 2500, 1600, 1450, 1050; 
δH (D2O) 3.30 and 3.45 (2H, 2 x dd overlapped, J 5.0, 7.6, and 14.0, CHCH2), 4.20 (1H, dd, J 5.0 
and 7.6, CHCH2), 7.40 (2H, m, pyridyl H3 and H5), 7.85 (1H, m, pyridyl H4), 8.60 (1H, m, 
pyridyl H6); m/z (CI) 167 (MH+, 3%), 148 (5), 121 (80), 93 (100) and 78 (15). 
2-Amino-3-(3-pyridyl)propanoic acid (3f). Prepared following the general method, using 
amide 2f (1.0 g, 3.66 mmol) in dioxane (5 mL) and water (20 mL). Work-up afforded the title 
compound (0.26 g, 49%). M.p. 253-254 ºC (lit.14 253-256 ºC); Found: MH+ (ES+) 167.0820. 
C8H10N2O2 requires: MH 167.0820; νmax/cm–1 (KBr) 3400, 2900, 2800, 2500, 1600, 1400, 1050; 
δH (D2O) 3.15 and 3.25 (2H, 2 x dd overlapped, J 14.8, 5.6 and 7.5, CHCH2), 4.05 (1H, dd, J 5.6 
and 7.5, CHCH2), 7.38 (1H, m, pyridyl H5), 7.73 (1H, m, pyridyl H4), 8.38-8.40 (2H, m, pyridyl 
H2 and H6); m/z (CI) 167 (MH+, 30%), 121 (100), 93 (40) and 52 (38). 
2-Amino-3-(4-pyridyl)propanoic acid (3g). Prepared following the general method, using 
amide 2g (1.0 g, 3.66 mmol) in dioxane (5 mL) and water (20 mL). Work-up afforded the title 
compound (0.21 g, 40%). M.p. 239-241 ºC (lit.14 246-248 ºC); Found: MH+ (ES+) 167.0821. 
C8H10N2O2 requires: MH 167.0820; νmax/cm–1 (KBr) 3350, 2900, 2750, 2500, 2200, 1600, 1400, 
1300, 1050; δH (D2O) 3.06 and 3.12 (2H, 2 x dd, J 5.9, 7.5 and 14.5, CHCH2), 4.05 (1H, dd, J 
5.9 and 7.5, CHCH2), 7.24-7.40 (4H, m, pyridyl H); δC (D2O) 38.3 (CH2), 57.6 (CHCH2), 128.4 
and 130.4 (2 x ArCH), 137.3 (ArC), 174.0 (C=O); m/z (EI) 166 (M+, 100%), 150 (5), 121 (12), 
88 (5) and 52 (28). 
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2-Amino-3-(3,5-dimethylisoxazol-4-yl)propanoic acid (3h). Prepared following the general 
method, using amide 2h (2.93 g, 8.84 mmol) in dioxane (5 mL) and water (20 mL). Work-up 
afforded pseudoephedrine (1.21 g, 62%) and the title compound (0.96 g, 59%). M.p. 216-217 ºC; 
Found: MH+ (ES+) 185.0927. C8H12N2O3 requires: MH 185.0926; νmax/cm–1 (KBr) 3400, 2950, 
2600, 2050, 1650, 1500, 1450, 1400, 1200; δH (D2O) 2.09 and 2.20 (2 x 3H, 2 x s, isoxazole 
CH3), 2.69-2.88 (2H, 2 x dd overlapped, J 7.0 and 15.4, CH2), 3.63 (1H, t, J 7.0, CH); δC (D2O) 
10.1 and 11.1 (isoxazole CH3) 24.5 (CH2), 55.1 (CH), 109.3, 161.9, and 169.2 (3 x ArC), 174.2 
(C=O); m/z (CI) 185 (MH+, 20%), 141 (50) and 124 (100). 
General method for conversion of an amino acid into its (S)-2-methoxy-2-phenyl-3,3,3-
trifluoropropanamide (Mosher amide) derivative. 
Acetyl chloride (10 mol equiv.) was added dropwise at 0 ºC to a stirred solution of the amino 
acid (~50 mg) in ethanol (approx. 40 mL). The mixture was then stirred overnight at 25 ºC, 
heated at reflux for 4 h, cooled and the solvent evaporated under reduced pressure to give the 
ethyl ester hydrochloride salt which was further dried under vacuum overnight. (R)-2-Methoxy-
2-phenyl-3,3,3-trifluoropropanoyI chloride (MTPA-Cl) (100 mg) was added dropwise at room 
temperature to the ester hydrochloride stirred in chloroform (4 mL) and pyridine (4 mL) . The 
mixture was stirred overnight, water (20 mL) was added and the mixture extracted with ethyl 
acetate (3 x 20 mL). The combined ethyl acetate layers were washed with saturated sodium 
hydrogen carbonate solution (3 x 10 mL), dried (MgSO4) and evaporated under reduced pressure 
to afford the product amide, that was directly analysed by 19F NMR spectroscopy for the 
determination of diastereomeric purity (and hence enantiomeric purity of the amino acid). 
(2'S)-Ethyl 2-(3,3,3-trifluoro-2-methoxy-2-phenylpropanoylamino)-3-phenylpropanoate 
(4a). Prepared as above using amino acid phenylalanine 3a (~50 mg). δF –69.09 (major 
diastereoisomer, 93.5%), –69.14 (minor diastereoisomer, 6.5%); ee 87%. 
(2'S)-Ethyl 2-(3,3,3-trifluoro-2-methoxy-2-phenylpropanoylamino)-3-(1-naphthyl)-
propanoate (4b). Prepared as above using amino acid 3b (~50 mg). δF –68.01 (major 
diastereoisomer, 93.5%), –68.09 (minor diastereoisomer, 6.5%); ee 87%. 
(2'S)-Ethyl 2-(3,3,3-trifluoro-2-methoxy-2-phenylpropanoylamino)-4-(l-naphthyl)-
butanoate (4c). Prepared following the general method using amino acid 3c (~50 mg). δF –68.08 
(minor diastereoisomer, 19.5%), –67.96 (major diastereoisomer, 80.5%); ee 61 %. 
(2'S)-Ethyl 2-(3,3,3-trifluoro-2-methoxy-2-phenylpropanoylamino)-3-(2-phenylphenyl)-
propanoate (4d). Prepared following the general method, using amino acid 3d (~50 mg). δF –
68.01 (major diastereoisomer, 87%), –68.13 (minor diastereoisomer, 13%); ee 74%. 
(2'S)-Ethyl 2-(3,3,3-trifluoro-2-methoxy-2-phenylpropanoylamino)-3-(2-pyridyl)-
propanoate, (4e). Prepared following the general method using amino acid 3e (~50 mg). δF –
69.15 (major diastereoisomer, 55%), –69.52 (minor diastereoisomer, 45%); ee 10%. 
(2'S)-Ethyl 2-(3,3,3-trifluoro-2-methoxy-2-phenylpropanoylamino)-3-(3-pyridyl)-
propanoate, (4f). Prepared following the general method using amino acid 4f (~50 mg). δF –
68.85 (minor diastereolsomer, 13%), –69.17 (major diastereoisomer, 87%); ee 74%. 
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(2'S)-Ethyl 2-(3,3,3-trifluoro-2-methoxy-2-phenylpropanoylamino)-3-(4-pyridyl)-
propanoate, (4g). Prepared following the general method using amino acid 4g (~50 mg). δF –
68.95 (minor diastereoisomer, 16%), –69.15 (major diastereoisomer, 84%); ee 68%. 
(2'S)-Ethyl 2-(3,3,3-trifluoro-2-methoxy-2-phenylpropanoylamino)-3-(3,5-dimethylisoxazol-
4-yl)propanoate (4h). Prepared following the general method, using amino acid 3h (~50 mg). δF 
–68.87 (major diastereoisomer, 87%), –69.00 (minor diastereoisomer, 13%); ee 74%. 
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